Tech Company Financing Transactions

Therini Bio Funding Round

On 4/27/2023, Therini Bio raised $36 million in Series A financing from Dementia Discovery Fund, MRL Ventures and Sanofi Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

681 Gateway Blvd. 411
San Francisco, CA 94080
USA

Phone

Undisclosed

Website

www.therinibio.com

Email Address

Not Recorded

Overview

Therini Bio, Inc. is a biotechnology company dedicated to the research and development of novel therapeutics for the treatment of neuroinflammatory diseases due to vascular dysfunction. Our approach will be generally applicable across a range of inflammatory diseases including peripheral indications.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Daniel Burgess

        

Founder

Katerina Akass

        

Browse more venture capital transactions:

Prev: 4/27/2023: POSH venture capital transaction
Next: 4/27/2023: DeepHow venture capital transaction

Share this article

About Our Venture Capital Transactions Database

Our team works diligently to document every notable VC transaction. VC transactions on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary